Key Factors That Lower Time in Therapeutic Range of Warfarin in Patients with Non-Valvular Atrial Fibrillation

被引：0
|
作者：
Tanaka, T. [1 ]
Ihara, M. [1 ]
Yamagami, H. [1 ]
Toyoda, K. [2 ]
Nagatsuka, K. [1 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan
[2] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan
来源：
CEREBROVASCULAR DISEASES | 2015年 / 40卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P084
引用
收藏
页码：70 / 70
页数：1
相关论文
共 50 条
  • [1] Warfarin in non-valvular atrial fibrillation
    Dalby, A. J.
    Wessels, P.
    Opie, L. H.
    SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2013, 103 (12): : 901 - 904
  • [2] TIME IN THERAPEUTIC RANGE ≥55% VERSUS <55% ON WARFARIN THERAPY OUTCOMES IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS
    An, Jaejin
    Lang, Daniel
    Fang, Niu
    Jazdzewski, Kristin
    Le, Paul
    Rashid, Nazia
    Meissner, Brian
    Mendes, Robert
    Dills, Diana
    Ershoff, Dan
    Borok, Gerald
    Bruno, Amanda
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A359 - A359
  • [3] PROVIDER INTERPRETATION AND UTILIZATION OF TIME IN THERAPEUTIC RANGE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Brunton, Nichole
    Rouzbehani, Jahangir
    Sostin, Oleg
    Wakefield, Dorothy
    Galin, Ira
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2104 - 2104
  • [4] Time in the Therapeutic Range During Warfarin Therapy in Japanese Patients With Non-Valvular Atrial Fibrillation - A Multicenter Study of Its Status and Influential Factors -
    Okumura, Ken
    Komatsu, Takashi
    Yamashita, Takeshi
    Okuyama, Yuji
    Harada, Masahiko
    Konta, Yoshiyuki
    Hatayama, Toru
    Horiuchi, Daisuke
    Tsushima, Eiki
    CIRCULATION JOURNAL, 2011, 75 (09) : 2087 - 2094
  • [5] REVIEW OF TIME IN THERAPEUTIC RANGE ON WARFARIN FOR NON-VALVULAR ATRIAL FIBRILLATION (NVAF) IN ADMISSIONS TO A GERIATRIC MEDICINE WARD
    Bhat, M.
    Jegard, J.
    Kaneshamoorthy, M.
    Yeo, J. H.
    O'Brien, A.
    AGE AND AGEING, 2018, 47 : 3 - 3
  • [6] Achievement of international normalized ratio therapeutic range among chronic non-valvular atrial fibrillation patients treated with warfarin
    Harley, CR
    Shetty, S
    Hauch, O
    Wygant, G
    Riedel, AA
    Nelson, M
    CIRCULATION, 2004, 109 (20) : E271 - E271
  • [7] Temporal trends of time in therapeutic range and incidence of cardiovascular events in patients with non-valvular atrial fibrillation
    Pastori, Daniele
    Farcomeni, Alessio
    Saliola, Mirella
    Del Sole, Francesco
    Pignatelli, Pasquale
    Violi, Francesco
    Lip, Gregory Y. H.
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2018, 54 : 34 - 39
  • [8] Barriers to using warfarin in non-valvular atrial fibrillation
    Gattellari, M
    Zwar, NA
    Worthington, JM
    Middleton, S
    BRITISH MEDICAL JOURNAL, 2006, 332 (7536): : 303 - 304
  • [9] Utilization of warfarin in elderly patients with non-valvular atrial fibrillation.
    Youssef, H
    Pomerantz, SC
    Ciesielski, J
    Cavalieri, TA
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2004, 52 (04) : S112 - S112
  • [10] DISCONTINUATION/INTERRUPTION OF WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
    Wang, J.
    Qiao, Y.
    Spivey, C. A.
    Liu, X.
    Phatak, H.
    Mardekian, J.
    Claflin, A. B.
    Kachroo, S.
    Abdulsatter, Y.
    Parker, R. B.
    VALUE IN HEALTH, 2014, 17 (07) : A763 - A763
12345